Gamma interferon modifies CD4+ subset expression in murine candidiasis

Area of Science:

• Immunology
• Microbiology
• Vaccinology

Background:

• The balance between T-helper 1 (Th1) and T-helper 2 (Th2) immune responses is critical for effective vaccination.
• Gamma interferon is a key cytokine associated with Th1 responses, crucial for cell-mediated immunity against fungal infections.
• Candida albicans is a common fungal pathogen, and effective vaccines are needed to prevent candidiasis.

Purpose of the Study:

• To investigate the impact of monoclonal antibodies against gamma interferon on immune responses induced by a live Candida albicans vaccine.
• To determine whether the antibody treatment influences the development of Th1 versus Th2 responses.
• To examine the effects on early gene expression of key cytokines in CD4+ T cells.

Main Methods:

• Administration of a live Candida albicans yeast cell vaccine.
• Co-administration of a single injection of monoclonal antibody to gamma interferon.
• Analysis of immune cell responses, specifically Th1 and Th2 profiles.
• Measurement of interleukin 4 and gamma interferon mRNA expression in CD4+ cells.

Main Results:

• The combined treatment resulted in the detection of nonprotective Th2 immune responses instead of protective Th1 responses.
• Early expression of interleukin 4 mRNA was detected.
• Early expression of gamma interferon mRNA was altered in CD4+ cells.

Conclusions:

• Monoclonal antibody targeting gamma interferon can redirect vaccine-induced immune responses from a protective Th1 profile to a nonprotective Th2 profile.
• This intervention affects the early transcriptional dynamics of immune signaling molecules in CD4+ T cells during vaccination.
• Findings suggest a potential strategy to modulate immune responses, but highlight the risk of inducing non-protective immunity.